New TB drug approval a milestone, all agree — with caveats, some add

By on .

The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against the deadliest and most resistant form of the disease represented a major step forward on multiple fronts, international treatment advocates agree. One of only three new drugs receiving regulatory […]

Amid other challenges, Burundi begins front-line, health worker Ebola vaccinations at border

By on .

DRC neighbor boosts preparedness for spread of virus while grappling with increasing malaria cases, continued cholera outbreak Burundi’s health ministry Tuesday launched a campaign to vaccinate  health workers and others on the front line of a Democratic Republic of Congo border crossing Tuesday, the most recent in a series of steps preparing for the eventuality […]

Improved Ebola survival rates with study treatments raise hopes, challenges

By on .

Announcing favorable results from two of four Ebola treatment candidates being used in a randomized clinical trial among patients in the ongoing Democratic Republic of Congo outbreak, officials from the National Institute of Allergy and Infectious Diseases, the World Health Organization, and a veteran Democratic Republic of Congo researcher today heralded preliminary data as yielding […]

When viral suppression didn’t last, lowering barriers to HIV treatment and care made a difference

By on .

The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. If 90 percent of all people living with the virus knew it, 90 percent of them access antiretroviral treatment, and 90 percent of those on treatment — that is […]

Activist confronts the “father” of drug-resistant TB

By on .

The following is a guest post by Abigail Mudd, MPH A human rights lawyer and two-time tuberculosis survivor, Timur Abdullaev is an international TB activist. He owes his life, he says, to treatment supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria, and now he also depends on the multilateral initiative for his […]

A year into DRC Ebola outbreak, control eludes the response while funding remains in question

By on .

On the eve of the day marking one year since recognition of the current Democratic Republic of Congo Ebola outbreak, in measured, if largely familiar words, two of the World Health Organization’s response leaders discussed the ongoing spread of the virus and the state of the response. That included confirmation of the virus in a […]

IAS 2019: Collapse of Venezuela’s health infrastructure dismantles HIV response

By on .

MEXICO CITY – A decade ago, Venezuela had one of the most progressive responses to its HIV epidemic in the world. In the 1990s the country’s Supreme Court mandated that the government provide lifesaving antiretroviral therapy, catalyzing a national HIV program which provided comprehensive care to everyone who qualified. Now, after more than five years […]

IAS 2019: Scientist highlights the weight of the smallest organism in HIV risk

By on .

MEXICO CITY – When you think of factors associated with increased risks of acquiring HIV, big pictures of marginalization, discrimination, geographic location, economic inequities and gender inequality might come to mind. With two maps here on Tuesday, a scientist zeroed in on a factor that, while literally microscopic, can also make a great difference: bacteria. On […]

IAS 2019: While plans for HIV control innovations accelerate, community input remains an afterthought

By on .

MEXICO CITY – “What HIV has pointed out is that building it does not make them come,” Ambassador Dr. Deborah Birx noted at an opening night press event that highlighted persisting gaps in HIV testing, treatment, prevention access across the globe. When services don’t reach clients and communities, she said, people offering them have to […]

IAS 2019: While dispelling concerns of DPM HIV risk, ECHO study yields data on STIs, PrEP interest, pregnancy rates

By on .

MEXICO CITY – Women using Depo Provera as a long acting, injectable hormonal contraceptive showed lower rates of sexually transmitted infection that include chlamydia and gonorrhea, during a study undertook with the primary aim of assessing whether the drug raised risks of HIV infection. This is one in several findings released Monday from the Evaluation of […]